513 related articles for article (PubMed ID: 33116505)
1. Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.
Bin-Jumah M; Gilani SJ; Jahangir MA; Zafar A; Alshehri S; Yasir M; Kala C; Taleuzzaman M; Imam SS
Int J Nanomedicine; 2020; 15():7861-7875. PubMed ID: 33116505
[TBL] [Abstract][Full Text] [Related]
2. Stimulus Responsive Ocular Gentamycin-Ferrying Chitosan Nanoparticles Hydrogel: Formulation Optimization, Ocular Safety and Antibacterial Assessment.
Alruwaili NK; Zafar A; Imam SS; Alharbi KS; Alotaibi NH; Alshehri S; Alhakamy NA; Alzarea AI; Afzal M; Elmowafy M
Int J Nanomedicine; 2020; 15():4717-4737. PubMed ID: 32636627
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
[TBL] [Abstract][Full Text] [Related]
4. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
[TBL] [Abstract][Full Text] [Related]
5. Investigating The Retention Potential of Chitosan Nanoparticulate Gel: Design, Development,
Kaul S; Jain N; Pandey J; Nagaich U
Recent Pat Antiinfect Drug Discov; 2020; 15(1):41-67. PubMed ID: 31612834
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of levofloxacin loaded chitosan nanoparticle for ocular delivery: In-vitro characterization, ocular tolerance and antibacterial activity.
Ameeduzzafar ; Imam SS; Abbas Bukhari SN; Ahmad J; Ali A
Int J Biol Macromol; 2018 Mar; 108():650-659. PubMed ID: 29199125
[TBL] [Abstract][Full Text] [Related]
7. Preparation and Evaluation of N-Trimethyl Chitosan Nanoparticles of Flurbiprofen for Ocular Delivery.
Shinde UA; Joshi PN; Jain DD; Singh K
Curr Eye Res; 2019 May; 44(5):575-582. PubMed ID: 30632402
[TBL] [Abstract][Full Text] [Related]
8. Optimization to development of chitosan decorated polycaprolactone nanoparticles for improved ocular delivery of dorzolamide: In vitro, ex vivo and toxicity assessments.
Shahab MS; Rizwanullah M; Alshehri S; Imam SS
Int J Biol Macromol; 2020 Nov; 163():2392-2404. PubMed ID: 32979440
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of Chitosan Nanoparticles for Ocular Delivery of Tedizolid Phosphate.
Kalam MA; Iqbal M; Alshememry A; Alkholief M; Alshamsan A
Molecules; 2022 Apr; 27(7):. PubMed ID: 35408724
[TBL] [Abstract][Full Text] [Related]
10. Physicochemical and anti-bacterial performance characterization of clarithromycin nanoparticles as colloidal drug delivery system.
Mohammadi G; Nokhodchi A; Barzegar-Jalali M; Lotfipour F; Adibkia K; Ehyaei N; Valizadeh H
Colloids Surf B Biointerfaces; 2011 Nov; 88(1):39-44. PubMed ID: 21752610
[TBL] [Abstract][Full Text] [Related]
11. Development and Characterization of Gefitinib Loaded Polymeric Nanoparticles by Ionic Gelation Method.
Gupta M; Marwaha RK; Dureja H
Pharm Nanotechnol; 2017; 5(4):301-309. PubMed ID: 28982345
[TBL] [Abstract][Full Text] [Related]
12. Chitosan nanoparticles amplify the ocular hypotensive effect of cateolol in rabbits.
Ameeduzzafar ; Ali J; Bhatnagar A; Kumar N; Ali A
Int J Biol Macromol; 2014 Apr; 65():479-91. PubMed ID: 24530326
[TBL] [Abstract][Full Text] [Related]
13. Development, optimization, and in vitro characterization of dasatinib-loaded PEG functionalized chitosan capped gold nanoparticles using Box-Behnken experimental design.
Adena SKR; Upadhyay M; Vardhan H; Mishra B
Drug Dev Ind Pharm; 2018 Mar; 44(3):493-501. PubMed ID: 29161920
[TBL] [Abstract][Full Text] [Related]
14. Development of Ciprofloxacin-Loaded Bilosomes In-Situ Gel for Ocular Delivery: Optimization, In-Vitro Characterization, Ex-Vivo Permeation, and Antimicrobial Study.
Alsaidan OA; Zafar A; Yasir M; Alzarea SI; Alqinyah M; Khalid M
Gels; 2022 Oct; 8(11):. PubMed ID: 36354595
[TBL] [Abstract][Full Text] [Related]
15. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
[TBL] [Abstract][Full Text] [Related]
16. Preparation of Chitosan Okra Nanoparticles: Optimization and Evaluation as Mucoadhesive Drug Delivery System.
Brar V; Kaur G
Pharm Nanotechnol; 2018; 6(3):180-191. PubMed ID: 30101724
[TBL] [Abstract][Full Text] [Related]
17. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies.
Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926
[TBL] [Abstract][Full Text] [Related]
18. Formulation of carteolol chitosomes for ocular delivery: formulation optimization,
Zafar A; Alruwaili NK; Imam SS; Alsaidan OA; Alharbi KS; Yasir M; Elmowafy M; Ansari MJ; Salahuddin M; Alshehri S
Cutan Ocul Toxicol; 2021 Dec; 40(4):338-349. PubMed ID: 34340615
[No Abstract] [Full Text] [Related]
19. Formulation and Evaluation of Moxifloxacin Loaded Bilosomes In-Situ Gel: Optimization to Antibacterial Evaluation.
Zafar A; Alsaidan OA; Imam SS; Yasir M; Alharbi KS; Khalid M
Gels; 2022 Jul; 8(7):. PubMed ID: 35877503
[TBL] [Abstract][Full Text] [Related]
20. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]